Table 3.
Number of subjects | Number of preeclampsia outcomes | Risk ratio stratified by depression status | |||||
---|---|---|---|---|---|---|---|
| |||||||
Exposedb | Unexposedb | Exposedb | Unexposedb | Adjusteda risk ratio (aRR) | Adjusteda risk ratio (aRR) in women without depression | Adjusteda risk ratio (aRR) in women with depression | |
|
|||||||
n=2368c | n=2144 | n=224 | |||||
Rheumatoid Arthritis | 726 | 1700 | 42 | 60 | 1.62 (1.04, 2.53) | 1.65 (1.04, 2.63) | 1.08 (0.21, 5.55) |
Depression | 0.94 (0.48, 1.88) | ||||||
n=1991 | n=1805 | n=186 | |||||
Crohn’s disease | 347 | 1700 | 18 | 60 | 1.67 (0.93, 3.00) | 1.82 (1.01, 3.30) | NE |
Depression | 0.56 (0.20, 1.54) | ||||||
n=1977 | n=1744 | n=203 | |||||
Psoriasis | 330 | 1700 | 21 | 60 | 1.57 (0.89, 2.77) | 1.58 (0.86, 2.89) | 1.39 (0.25, 7.61) |
Depression | 0.73 (0.33, 1.59) |
Propsensity scores for adjustment include race/ethnicity, socioeconomic status, medical comorbidities, pregnancy smoking, pre-pregnancy BMI, and maternal age, and gestational age at enrollment.
Number of subjects exposed and unexposed to select autoimmune condition.
n’s represent complete case analysis.
NE=no estimate. There were no cases of preeclampsia among individuals with Crohn’s disease in the stratum with depression.